MARKET

IART

IART

Integra Lifesciences Hldgs Cp
NASDAQ
31.94
+0.41
+1.30%
Opening 10:12 07/26 EDT
OPEN
31.77
PREV CLOSE
31.53
HIGH
32.19
LOW
31.64
VOLUME
97.01K
TURNOVER
0
52 WEEK HIGH
46.75
52 WEEK LOW
22.36
MARKET CAP
2.52B
P/E (TTM)
62.89
1D
5D
1M
3M
1Y
5Y
1D
Pre-Market Earnings Report for July 29, 2024 : MCD, ON, RVTY, CNA, AMG, ARLP, IART, HOPE, BMRC, OIS, CIVB, PROV
NASDAQ · 5h ago
Integra LifeSciences Holdings Q2 2024 Earnings Preview
Integra LifeSciences Holdings Corporation (IART) is scheduled to announce Q2 earnings results on Monday, July 29th. The consensus EPS Estimate is $0.62 and the consensus revenue estimate is $413.12M. Over the last 2 years, IART has beaten EPS estimates 63% of the time.
Seeking Alpha · 6h ago
Notable earnings before Monday's open
Major earnings expected before the bell on Monday include: McDonald's, ON Semiconductor, and Loews. Other major earnings slated for release before Monday's open include: AMG, CNA, and AVTR. Notable earnings before the open include Alliance Resource Partners and McDonald's.
Seeking Alpha · 10h ago
Integra Lifesciences Holdings Corp <IART.OQ> expected to post earnings of 62 cents a share - Earnings Preview
Integra Lifesciences Holdings Corp expected to post earnings of 62 cents a share. The company is expected to report a 8.4% increase in quarterly revenue to $413.154 million for the period ending June 30 2024.
Reuters · 11h ago
Weekly Report: what happened at IART last week (0715-0719)?
Weekly Report · 4d ago
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
Kahn Swick & Foti, LLC has commenced an investigation into Integra LifeSciences Holdings Corporation. On May 23, 2023, Integra recalled all medical device products made at its Boston Facility. The Company and certain of its executives were sued in a securities class action lawsuit. KSF’s investigation is focusing on whether Integra violated federal securities laws.
Barchart · 07/19 16:50
Implied Volatility Surging for Integra (IART) Stock Options
NASDAQ · 07/19 12:34
Integra LifeSciences Price Target Raised to $32.00/Share From $25.00 by Truist Securities
Dow Jones · 07/16 13:58
More
About IART
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Webull offers Integra Lifesciences Holdings Corp stock information, including NASDAQ: IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.